Neo Ivy Capital Management’s Repligen RGEN Stock Holding History

Neo Ivy Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$164K	Buy	+1,394	New	+$195K	0.04%	272
2025 Q2	–	Sell	-16,436	Closed	-$2.09M	–	452
2025 Q1	$2.09M	Buy	+16,436	New	+$2.53M	0.67%	61
2024 Q3	–	Sell	-23,148	Closed	-$2.92M	–	376
2024 Q2	$2.92M	Buy	+23,148	New	+$3.63M	0.57%	80
2023 Q4	$164K	Buy	+912	New	+$142K	0.37%	93
2023 Q3	–	Sell	-2,094	Closed	-$296K	–	436
2023 Q2	$296K	Buy	+2,094	New	+$336K	0.16%	197
2021 Q4	–	Sell	-39	Closed	-$5K	–	599
2021 Q3	$5K	Buy	+39	New	+$10K	0.01%	428
2021 Q2	–	Sell	-291	Closed	-$57K	–	583
2021 Q1	$57K	Buy	+291	New	+$59.7K	0.06%	317
2020 Q3	–	Sell	-39	Closed	-$5K	–	593
2020 Q2	$5K	Sell	39 -1,396	-97%	-$164K	0.01%	428
2020 Q1	$139K	Buy	+1,435	New	+$139K	0.23%	182
2019 Q1	–	Sell	-6,831	Closed	-$360K	–	384
2018 Q4	$360K	Buy	+6,831	New	+$401K	0.28%	157

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Neo Ivy Capital Management's RGEN Position: Q1 2026 in Review

Neo Ivy Capital Management opened a new position in Repligen (RGEN) in Q1 2026: 1,394 shares worth $164K. The stake represents 0.04% of the portfolio and ranks #272 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in RGEN as recently as Q1 2025.

Neo Ivy Capital Management first reported a position in RGEN in Q4 2018 and has held it in 10 quarters since. The position peaked at $2.92M in Q2 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

Neo Ivy Capital Management held 1,394 shares of Repligen worth $164K as of Q1 2026.
Repligen was a new Neo Ivy Capital Management position in Q1 2026.
Repligen made up 0.04% of Neo Ivy Capital Management's portfolio in Q1 2026, its #272 holding.
Neo Ivy Capital Management first reported a position in Repligen in Q4 2018 and has held it in 10 quarters since.
Neo Ivy Capital Management's Repligen position peaked at $2.92M in Q2 2024.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.